Apg Asset Management N.V. Regeneron Pharmaceuticals, Inc. Transaction History

Apg Asset Management N.V.

$59.3 Billion
Q2 2024

A detailed history of Apg Asset Management N.V. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 127,424 shares of REGN stock, worth $134 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

127,424

Previous 143,767 11.37%

Holding current value

$134 Million

Previous $138 Million 3.21%

% of portfolio

0.23%

Previous 0.23%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $14.4 Million - $17.5 Million	-16,343 Reduced 11.37%	127,424 $134 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $2.53 Million - $2.79 Million	-2,807 Reduced 1.92%	143,767 $138 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $2.39 Million - $2.71 Million	3,077 Added 2.14%	146,574 $129 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $2.22 Million - $2.71 Million	-3,207 Reduced 2.19%	143,497 $118 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $4.34 Million - $5.15 Million	-6,205 Reduced 4.06%	146,704 $105 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $16.7 Million - $20.3 Million	-24,551 Reduced 13.83%	152,909 $126 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $13.3 Million - $14.5 Million	18,869 Added 11.9%	177,460 $128 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $53.2 Million - $67.2 Million	-92,715 Reduced 36.89%	158,591 $112 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $67.6 Million - $91.1 Million	-123,289 Reduced 32.91%	251,306 $142 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $19.7 Million - $23.1 Million	-33,029 Reduced 8.1%	374,595 $235 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $4.46 Million - $5.5 Million	-8,200 Reduced 1.97%	407,624 $226 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $4.71 Million - $5.58 Million	-8,200 Reduced 1.93%	415,824 $217 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $414,645 - $489,839	-877 Reduced 0.21%	424,024 $200 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $14.1 Million - $17.3 Million	-31,568 Reduced 6.92%	424,901 $171 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $55.3 Million - $70.3 Million	115,711 Added 33.96%	456,469 $180 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $13.3 Million - $16.1 Million	24,500 Added 7.75%	340,758 $163 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $130 Million - $170 Million	264,471 Added 510.69%	316,258 $176 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $32.8 Million - $48.2 Million	-97,495 Reduced 65.31%	51,787 $25.3 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $40 Million - $58.8 Million	118,872 Added 390.9%	149,282 $54.6 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $1.63 Million - $2.24 Million	5,950 Added 24.33%	30,410 $10.2 Million
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $34.2 Million - $39.8 Million	-124,922 Reduced 83.63%	24,460 $6.22 Million
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $29,960 - $41,482	100 Added 0.07%	149,382 $41.1 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $48.7 Million - $57.5 Million	130,900 Added 712.11%	149,282 $54.6 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $67,164 - $80,608	-200 Reduced 1.08%	18,382 $6.01 Million
Q4 2017 Jan 24, 2018	SELL	$358.63 - $469.95 $851,746 - $1.12 Million	-2,375 Reduced 11.33%	18,582 $5.82 Million
Q3 2017 Oct 19, 2017	BUY	$431.38 - $504.0 $9.04 Million - $10.6 Million	20,957	20,957 $9.37 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Regeneron Pharmaceuticals, Inc. Transaction History